Table 1 The correlation of tumor size with clinicopathologic characteristics of 943 patients with papillary thyroid carcinoma between 2014 and 2016
Variable | Overall PTC (n = 943) | PTC > 10 mm (n = 373) | PTMC (n = 570) | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|---|---|
n | (%) | n | (%) | n | (%) | P | P | OR(95CI) | |
Gender | |||||||||
 Male | 233 | (25) | 107 | (29) | 126 | (22) | 0.02 | 0.899 | 0.98(0.70–1.38) |
 Female | 710 | (75) | 266 | (71) | 444 | (78) | |||
Age (years) * | (45.9 ± 11.3) | (45.4 ± 12.0) | (46.3 ± 10.8) | 0.265 |  |  | |||
Focality | |||||||||
 Uni | 588 | (73) | 259 | (69) | 429 | (75) | 0.05 | 0.178 | 1.25(0.90–1.73) |
 Multi | 255 | (27) | 114 | (31) | 141 | (25) | |||
HT | |||||||||
 Yes | X50 | (5) | 15 | (4) | 35 | (6) | 0.159 |  |  |
 No | 893 | (95) | 358 | (96) | 535 | (94) | |||
CLNM | |||||||||
 Yes | 505 | (53) | 275 | (74) | 230 | (40) | < 0.001 | <0.001 | 4.10(3.04–5.53) |
 No | 438 | (47) | 98 | (26) | 340 | (60) | |||
TNM staging | |||||||||
 I | 856 | (91) | 320 | (86) | 536 | (94) | < 0.001 | 0.554 | 1.19(0.66–2.15) |
 II | 87 | (9) | 53 | (14) | 34 | (6) | |||
BRAFV600E mutation | |||||||||
 Yes | 806 | (85) | 311 | (83) | 495 | (87) | 0.141 |  |  |
 No | 137 | (15) | 62 | (17) | 75 | (13) | |||